摘要
目的探讨急性缺血性脑卒中患者治疗前后血清同型半胱氨酸变化及其临床意义。方法随机选取该院收治的急性缺血性脑卒中患者93例作为观察组,并随机选取47例健康体检者作为对照组,对比分析观察组治疗前后以及对照组的Hcy水平。结果急性缺血性脑卒中患者治疗前Hcy水平为(23.37±6.26)U/L,显著高于对照组Hcy水平(8.93±1.32)U/L,差异有统计学意义(P<0.05);急性缺血性脑卒中患者治疗后Hcy水平为(17.94±4.23)U/L,与治疗前Hcy水平比较显著降低,差异有统计学意义(P<0.05)。结论血清同型半胱氨酸水平变化可以为急性缺血性脑卒中的诊断和治疗提供重要的临床价值。
Objective To investigate the changes of serum homocysteine levels in patients with acute ischemic stroke before and after treatment and its clinical significance. Methods 93 cases with acute ischemic stroke admitted in our hospital were randomly selected as the observation group, and other 47 cases with health examination were randomly selected as the con-trol group. The Hcy levels of the observation group before and after treatment were compared and analyzed, and the Hcy levels of the observation group before treatment and those of the control group were compared and analyzed. Results Before treatment, the Hcy levels of the acute ischemic stroke patients were much higher than those of the control group [(23.37 ± 6.26)U/L vs (8.93±1.32)U/L], the difference was statistically significant(P〈0.05). After treatment, the Hcy levels of the acute ischemic stroke patients were (17.94±4.23)U/L, which were much lower than those before treatment, the difference was sta-tistically significant (P〈0.05). Conclusion Serum homocysteine levels can provide important clinical value for the diagnosis and treatment of acute ischemic stroke.
出处
《中外医疗》
2015年第33期58-59,共2页
China & Foreign Medical Treatment